目前还没有针对淋巴细胞性脉络丛脑膜炎病毒(LCMV)感染的疫苗或疗法。这种病原体很容易传播，在世界各地的人群中极为常见。拉霍亚免疫研究所(LJI)的科学家们的新发现展示了工程抗体如何靶向LCMV并中和病毒。 淋巴细胞性 ...

仿真分析结果表明，相比于集中式LCMV，DNBD-LCMV对语音活动检测器误差和声学传递函数估计误差的鲁棒性更高；相比于只使用一个节点接收信号的S-LCMV ...

动物模型构建：使用特定病原体 - free（SPF）小鼠、无菌（GF）小鼠和定植了低复杂度细菌群落（OMM 12 ）的小鼠，为研究肠道微生物群的作用提供了不同的实验对象。; 病毒感染实验：给小鼠静脉注射 LCMV Cl-13 毒株，模拟病毒感染过程，观察小鼠的免疫反应和疾病进展。

A window into LCMV. Lassa virus and LCMV both belong to the Arenaviridae family. Lassa also infects rodents, but it is much more likely than LCMV to cause serious symptoms, even death, in human hosts.

Systematic assessment of LCMV based vaccine vectors expressing melanocyte differentiation antigens in human in vitro assays and in mouse melanoma models.. JCO 37 , e14299-e14299 (2019). DOI: ...

Background: Active immunization against cancer requires the induction of exquisitely potent tumor-specific CD8 + T cell (CTL) responses, which can be repeatedly boosted and reactivated. Hookipa Pharma ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Mathur, Neha. (2023, October 09). Immature immune cells near dural sinuses linked to neonatal ...

Background and epidemiology: In May 2005, the US Centers for Disease Control and Prevention (CDC) reported cases of lymphocytic choriomeningitis virus (LCMV) infection in 4 people who had received ...

--HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced a publication ...

HB-201 is one of HOOKIPA’s lead oncology candidates. It targets HPV16 E6/E7 and is based on the Company’s replicating LCMV (TheraT ®) arenaviral vector platform.It is currently in Phase 1/2 ...